Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress

Clinical and Experimental Hypertension

Volumn 31, Issue 1, 2009, Pages 83-91

  Morimoto, Satoshi ^a,b   Jo, Fusakazu ^a   Maki, Kei ^a   Iwasaka, Toshiji ^b  

^a Ohmihachiman Community Medical Center   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Efonidipine; Heart rate; Hypertension; Stress; T type calcium channel blockers

Indexed keywords

ADRENALIN; ALDOSTERONE; EFONIDIPINE; NORADRENALIN; RENIN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HEART RATE; HUMAN; MALE; PHYSICAL STRESS;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; DIHYDROPYRIDINES; HEART RATE; HUMANS; MALE; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 60549107508     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802627363     Document Type: Article

References (20)

1. 2+ channels. Cardiovasc Drug Rev. 2002;20:81-92.
2. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1998;395:233-253.
3. Shimizu M, Ogawa K, Sasaki H, Uehara Y, Otsuka Y, Okumura H, Kusaka M, Hasuda T, Yamada T, Mochizuki S. Effect of efonidipine, an L- and T-type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: An uncontrolled, open-label pilot study. Current Ther Res. 2003;64:707-714.
4. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J. 1993;125:1148-1154.
5. Wittert GA, Or HK, Livesey JH, Richards AM, Donald RA, Espiner EA. Vasopressin, corticotrophin-releasing factor, and pituitary adrenal responses to acute cold stress in normal humans. J Clin Endocrinol Metab. 1992;75:750-755.
6. Ng AV, Callister R, Johnson DG, Seals De. Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol. 1994;267:H344-H353.
7. Delarue J, Matzinger O, Binnert C, et al. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 2003;29:289-295.
8. Nakashima M, Kanamaru M, Uematsu T, Sato R, Mizuno A, Nagashima S, Takiguchi S, Tanaka S, Hibi M, Saito T, Yoshida Y. Pharmacokinetics and safety of NZ-105 in healthy volunteers: single-dose and multiple-dose studies. Jpn J Clin Pharmacol Ther. 1991;22:673-683.
9. Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens. 2001;19:863-869.
10. 123I-metaiodobenzylguanidine myocardial scintigraphy. Circ J. 2003;67:139-145.
11. 2+ currents in single canine Purkinje cells. Circ Res. 1989;65:1735-1750.
12. Clozel JP, Ertel EA, Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro40-5967), the first selective T-type calcium channel blocker. J Hypertens. 1997;15 (suppl 5):S17-S25.
13. Tzivoni D, Kadr H, Braat S, Rutsch W, Ramires JA, Kobrin I. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia. Circulation 1997;96:2557.
14. Tanaka H, Masumiya H, Sekine T, Sijuku T, Sugahara M, Taniguchi H, Terada M, Saito W, Shigenobu K. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem. Gen Pharmac. 1996;27:451-454.
15. Minami J, Ishimitsu T, Higashi T, Numabe A, Matsuoka H. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. Hypertens Res. 1998;21:215-219.
16. Morimoto S, Takeda K, Oguni A, Kido H, Harada S, Moriguchi J, Itoh H, Nakata T, Sasaki S, Nakagawa M. Reduction of white coat effect by cilnidipine in essential hypertension. Am J Hypertens. 2001;14:1053-1057.
17. Pellizer AM, Kamen PK, Esler MD, Lim S, Krum H. Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild and moderate essential hypertension. J Hypertens. 2001;19:279-285.
18. Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y, Shiroshita-Takeshita A, Miyoshi S, Hara M, Takatsuki S, Ogawa S. A Comparison between calcium channel blocking drugs with different potencies for T- and L-Type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol. 2004;44:386-392.
19. Clozel JP, Ertel EA, Ertel SI. Voltage-gated T-type Ca2+ channels and heart failure. Proc Assoc Am Physicians 1999;111:429-437.
20. Huang B, Qin D, Deng L, Boutjdir M, E1-Sherif N. Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res. 2000;46:442-449.